SFCL
VRTX icon

Strengthening Families & Communities LLC’s Vertex Pharmaceuticals VRTX Stock Holding History

Strengthening Families & Communities LLC’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.95K Buy
14
+1
+8% +$443 ﹤0.01% 427
2026
Q1 		$5.8K Sell
13
-74
-85% -$34.5K ﹤0.01% 420
2025
Q4 		$39.4K Buy
87
+77
+770% +$33.2K 0.01% 150
2025
Q3 		$3.92K Hold
10
– – ﹤0.01% 449
2025
Q2 		$4.45K Hold
10
– – ﹤0.01% 264
2025
Q1 		$4.85K Hold
10
– – ﹤0.01% 277
2024
Q4 		$4K Hold
10
– – ﹤0.01% 259
2024
Q3 		$4.65K Hold
10
– – ﹤0.01% 393
2024
Q2 		$5K Buy
10
+9
+900% +$3.91K ﹤0.01% 427
2024
Q1 		$0 Hold
1
– – ﹤0.01% 229
2023
Q4 		$407 Hold
1
– – ﹤0.01% 213
2023
Q3 		$0 Hold
1
– – ﹤0.01% 456
2023
Q2 		$0 Sell
1
-1
-50% -$337 ﹤0.01% 463
2023
Q1 		$1 Hold
2
– – ﹤0.01% 363
2022
Q4 		$1K Hold
2
– – ﹤0.01% 336
2022
Q3 		$0 Hold
2
– – ﹤0.01% 537
2022
Q2 		$1K Hold
2
– – ﹤0.01% 340
2022
Q1 		$1K Hold
2
– – ﹤0.01% 337
2021
Q4 		$0 Buy
+2
New +$389 ﹤0.01% 306

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Strengthening Families & Communities LLC's VRTX Position: Q2 2026 in Review

Strengthening Families & Communities LLC increased its Vertex Pharmaceuticals (VRTX) stake by 7.7% in Q2 2026, buying an estimated $443 and bringing the position to 14 shares worth $6.95K. The position accounts for ﹤0.01% of the portfolio, ranked #427.

Strengthening Families & Communities LLC first reported a position in VRTX in Q4 2021 and has held it in 19 quarters since. The position peaked at $39.4K in Q4 2025. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Strengthening Families & Communities LLC held 14 shares of Vertex Pharmaceuticals worth $6.95K as of Q2 2026.
  • Strengthening Families & Communities LLC bought 1 Vertex Pharmaceuticals share in Q2 2026, an estimated $443.
  • Vertex Pharmaceuticals made up ﹤0.01% of Strengthening Families & Communities LLC's portfolio in Q2 2026, its #427 holding.
  • Strengthening Families & Communities LLC first reported a position in Vertex Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • Strengthening Families & Communities LLC's Vertex Pharmaceuticals position peaked at $39.4K in Q4 2025.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Strengthening Families & Communities LLC's 13F filing for Q2 2026, filed 11 Aug 2026.